Giant cell myocarditis with central diabetes insipidus: A case report
2019
Abstract A 51-year-old male, previously diagnosed with central
diabetes insipidusdue to lymphocytic
hypophysitis, presented with fever and dyspnea for 1 week. On arrival, he exhibited hypotension (85/60 mmHg) and
sinus tachycardia(110 bpm). His electrocardiogram revealed mild
ST elevationon V2–V4. Echocardiography indicated a near-normal (50%) left ventricular ejection fraction (LVEF), although the inferior wall of the left ventricle exhibited severe hypokinesis. Fulminant
myocarditisand circulatory insufficiency were suspected, and treatment with
dobutamine, 3 μg/kg/min, was started. His LVEF gradually decreased to 20%. On day 17, he developed
cardiogenic shockdue to ventricular tachycardia and underwent peripheral venous–arterial
extracorporeal membrane oxygenationand
intra-aortic balloon pumping. Although he did not exhibit
polyuria, intravenous vasopressin infusion (0.5 U/h) was performed to maintain normonatremia. Endomyocardial biopsy results revealed the infiltration of scattered giant cells (GCs) and extensive lymphocytes. Despite immunosuppressive therapy (methylprednisolone and cyclosporine), his cardiac function did not recover. On day 36, he received a biventricular assist device; however, he died on day 47 due to the progression of sepsis and multiple organ failure. We speculate that a deficient expression of programmed cell death protein-1 was the cause of both GC
myocarditisand lymphocytic
hypophysitis.
Keywords:
-
Correction
-
Source
-
Cite
-
Save
10
References
0
Citations
NaN
KQI